PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets
- 15 November 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 102 (10) , 3658-3664
- https://doi.org/10.1182/blood-2003-06-1888
Abstract
Platelet adhesion at sites of vascular injury is mediated, in part, by interaction of the platelet plasma membrane glycoprotein (GP) Ib/V/IX complex with von Willebrand Factor (VWF) presented on collagen-exposed surfaces. Recent studies indicate that GPIb/V/IX may be functionally coupled with the Fc receptor γ (FcRγ)-chain, which, by virtue of its cytoplasmic immunoreceptor tyrosine-based activation motif, sends activation signals into the cell. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is an inhibitory receptor that has previously been shown to negatively regulate platelet responses to collagen, which transduces activation signals via the GPVI/FcRγ-chain complex. To determine whether PECAM-1 might similarly regulate signals emanating from GPIb/FcRγ, we compared activation and aggregation responses to VWF of PECAM-1-positive and PECAM-1-deficient murine platelets. PECAM-1 and the FcRγ-chain became rapidly tyrosine phosphorylated in platelets following botrocetin-induced VWF binding, but FcRγ-chain tyrosine phosphorylation was delayed in PECAM-1-positive, versus PECAM-1-deficient, platelets. PECAM-1-deficient platelets were hyperaggregable to VWF, exhibited enhanced spreading and, under conditions of arterial flow, formed markedly larger thrombi on immobilized VWF than did wild-type platelets. Taken together, these data support the notion that engagement of the GPIb complex, in addition to sending activation signals, also initiates a negative feedback loop involving PECAM-1 that controls the rate and extent of platelet activation. (Blood. 2003;102:3658-3664)Keywords
This publication has 49 references indexed in Scilit:
- Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)–mediated activation, and autoimmune diseaseBlood, 2002
- Platelet Activation by von Willebrand Factor Requires Coordinated Signaling through Thromboxane A2 and FcγIIA ReceptorPublished by Elsevier ,2001
- Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56lckBlood, 2001
- Synergistic Adhesive Interactions and Signaling Mechanisms Operating between Platelet Glycoprotein Ib/IX and Integrin αIIbβ3Published by Elsevier ,2000
- Signaling across the Platelet Adhesion Receptor Glycoprotein Ib-IX Induces αIIbβ3 Activation Both in Platelets and a Transfected Chinese Hamster Ovary Cell SystemJournal of Biological Chemistry, 2000
- A Novel Association of Fc Receptor γ-Chain with Glycoprotein VI and Their Co-expression as a Collagen Receptor in Human PlateletsJournal of Biological Chemistry, 1997
- The biology of PECAM-1.Journal of Clinical Investigation, 1997
- The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments.The Journal of cell biology, 1991
- Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis.Journal of Clinical Investigation, 1982
- Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.Journal of Clinical Investigation, 1976